The morbidity of bone disease in thalassemia

Annals of the New York Academy of Sciences

Volumn 850, Issue , 1998, Pages 344-348

  Vichinsky, Elliott P ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; DEFEROXAMINE MESYLATE; ESTROGEN; HEMOGLOBIN; IRON; TESTOSTERONE;

ABSORPTIOMETRY; AGING; BACKACHE; BONE DENSITY; BONE DISEASE; BONE MARROW DISEASE; BONE REMODELING; CONFERENCE PAPER; DELAYED PUBERTY; DYSPNEA; FRACTURE; HORMONE DEFICIENCY; HUMAN; INTRANASAL DRUG ADMINISTRATION; IRON STORAGE; MORBIDITY; NERVE COMPRESSION; NUTRITIONAL DEFICIENCY; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATIENT EDUCATION; RICKETS; RISK FACTOR; SCOLIOSIS; SPINE MALFORMATION; THALASSEMIA;

EID: 0031851068     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10491.x     Document Type: Conference Paper

References (32)

1. FILOSA, A., S. DIMAIO, A. SAVIANO, S. VOCCA & G. Esposrro. 1996. Can adrenarche influence the degree of osteopenia in thalassemia children? J. Pediatr. Endocrinol. Metab. 9: 401-406.
2. LOREY, F. 1997. California newborn screening and the impact of Asian immigration on thalassemia. Int. J. Ped. Hematol/Oncol. 4: 11-16.
3. KRISHNAN, S., W. C. STURTRIDGE, N. F. OLIVIERI, A. F. COLLINS, R. Y. QURESHI, M. KRISHNAN et al. 1994. A study on children's condition thalassemia using neutron activation analysis and other techniques. Biol. Trace Elem. Res. 43: 309-314.
4. OLIVIERI, N. F., R. K. BASRAN, A. L. TALBOT, P. BABYN & J. D. BAILEY. 1995. Abnormal growth in thalassemia major associated with deferoxamine-induced destruction of spinal cartilage and compromise of sitting height. Blood 86(Suppl 1): 482a.
5. POOTRAKUL P., S. HUNGSPRENGES, S. FUCHAROEN, D. BAYLINK, E. THOMPSON, E. ENGLISH et al. 1981. Relation between erythropoiesis and bone metabolism in thalassemia. N. Engl. J. Med. 304:1470-1473.
6. SERGIACOMI, G., E. PALMA, P. CIANCIULLI, L. FORTE, G. PAPA & G. SIMONETTI. 1993. Clinico-radiological correlation in thalassemia intermedia. Radiol. Med. (Torino) 85: 570-573.
7. PEARSON, H. A. 1997. The evaluation of thalassemia intermedia. In Proceedings of Thalassemia Intermedia: A Region I Conference. The Genetic Resource: Special Issue: 11: 5-10.
8. PEARSON, H. A., A. R. COHEN, P. J. GIARDINA & H. H. KAZAZIAN. 1996. The changing profile of homozygous β-thalassemia: Demography, ethnicity and age distribution of current North American patients and changes in two decades. Pediatrics 97: 352-356.
9. CANATAN, D., N. AKAR & A. ARCASOY. 1995. Effects of calcitonin therapy on osteoporosis in patients with thalassemia. Acta Haematol. 93: 20-24.
10. KOROVESSIS, P, D. PAPANASTASIOU, M. TINIAKOU & N. G. BERATIS. 1996. Incidence of scoliosis in β-thalassemia and follow-up evaluation. Spine 21: 1798-1801.
11. OLIVIERI, N. F., G. KOREN, J. HARRIS, S. KHATTAK, M. H. FREEDMAN, D. M. TEMPLETON et al. 1992. Growth failure and bony changes induced by deferoxamine. Am. J. Ped. Hematol/Oncol. 14: 48-56.
12. ORVIETO, R., I. LEICHTER, E. A. RACHMILEWITZ & J. Y. MARGULIES. 1992. Bone density, mineral content and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions and treatment with desferrioxamine. Calcif. Tissue Int. 50: 397-399.
13. RODDA C. P., E. D. REID, S. JOHNSON, J. DOERY, R. MATTHEWS & D. K. BOWDEN. 1995. Short stature in homozygous β-thalassaemia is due to disproportionate truncal shortening. Clin. Endocrinol. 42: 587-592.
14. CANN, C. E., M. C. MARTIN, H. K. GENANT & R. B. JAFFE. 1984. Decreased spinal mineral content in amenorrheic women. J. Am. Med. Assoc. 251: 626-629.
15. BISBOCCI, D., P. LIVORNO, P. MODINA, M. GAMBINO, P. DAMIANO, R. CANTONI et al. 1993. Osteodystrophy in thalassemia major. 8: 224-226.
16. ZAINO, E. C., K. J. YEH & J. ALOIA. 1985. Defective vitamin D metabolism in thalassemia major. Ann. N.Y. Acad. Sci. 445: 127-134.
17. Consensus Development Conference: Diagnosis, prophylaxis and treatment of osteoporosis. Peck W. A., Chairman. 1993. Am. J. Med. 94: 646-650.
18. DEVIRGILLIS, S. T., M. CONIGA & F. FRAY et al. 1988. Deferoxamine induced growth retardation in patients with thalassemia major. J. Pediatr. 113: 661-669.
19. FINKELSTEIN, J. S., R. M. NEER, B. M. K. BILLER, J. D. CRAWFORD & A. KLIBANSKI. 1992. Osteopenia in men with a history of delayed puberty. N. Engl. J. Med. 326: 600-604.
20. LINDSAY, R. 1993. Prevention and treatment of osteoporosis. Lancet 341: 801-805.
21. WARREN M. P., J. BROOKS-GUNN, L. H. HAMILTON, L. F. WARREN & W. G. HAMILTON. 1986. Scoliosis and fractures in young ballet dancers. N. Engl. J. Med. 314: 1348-1353.
22. MILLER P. D., S. L. BONNICK, C. J. ROSEN, R. D. ALTMAN, L. V. AVIOLI, J. DEQUEKER et al. Clinical utility of bone mass measurements in adults: Consensus of an international panel. 1996. Semin. Arthritis Rheum. 25: 361-372.
23. ABBOTT, T. A., III, B. J. LAWRENCE & S. WALLACH. 1996. Osteoporosis: The need for comprehensive treatment guidelines. Clin. Ther. 18: 127-149.
24. PEDRAZZONI, M, F. S. ALFANO, C. GATTI, M. FANTUZZI, G. GIRASOLE, C. CAMPANINI et al. 1995. Acute effects of bisphosphonates on new and traditional markers of bone resorption. Calcif. Tissue Int. 57: 25-29.
25. SATO, M., W. GRASSER & N. ENDO. 1991. Bisphosphonate action: Alendronate localization in rat bone and effects on osteoclast ultrastructure. J. Clin. Invest. 88: 2095-2105.
26. JOHNSTON, C. C. JR., J. Z. MILLER & C. W. SLEMENDA. 1993. Calcium supplementation and increases in bone mineral density in children. N. Engl. J. Med. 327: 82-87.
27. CHESTNUT, C. H., III, M. R. MCCLUNG, K. E. ENSRUD, N. H. BELL, H. K. GENANT, S. T. HARRIS et al. 1995. Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling. Am. J. Med. 99: 144-152.
28. HEANEY, R. P. 1993. Nutritional factors in osteoporosis. Annu. Rev. Nutr. 13: 287-316.
29. STYLES, L. A., D. H. FOOTE, K. M. KLEMAN, C. J. KLUMPP, N. B. HEER & E. P. VICHINSKY. 1997. Hemoglobin H-Constant Spring Disease: An under recognized, severe form of α-thalassemia. Intl. J. Pediatr. Hematol/Oncol. 4: 69-74.
30. ANAPUOTOU, M. L, I. T. KASTANUS, P. PSARA, E. A. EVANGELOU, M. LIPARAKI & P. DIMITRIOU. 1995. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: New therapeutic approaches. Clin. Endocrinol. 42: 279-287.
31. JACKSON, E. C., F. STRIFE, R. C. TSANO & H. MARDER. 1988. Effect of calcitonin replacement therapy in idopathic juvenile osteoporosis. Am. J. Dis. Child. 142: 1237-1239.
32. LINDSAY, R. 1988. Sex steroids in the pathogenesis and prevention of osteoporosis. In Osteoporosis: Etiology, Diagnosis and Management. B. L. Riggs, Ed.: 333-358. Raven Press. New York.